⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Clinical Study to Establish the Feasibility and Usability of the EndoRings™

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Clinical Study to Establish the Feasibility and Usability of the EndoRings™

Official Title: EndoRings™ - Clinical Protocol

Study ID: NCT01868971

Interventions

EndoRings

Study Description

Brief Summary: The purpose of this prospective clinical study is to establish the feasibility and usability of the ENDORINGS™ when used during standard colonoscopy procedure.

Detailed Description: The EndoAid Ltd. EndoRings is used during endoscopy procedures. The EndoRings is a short silicon rubber tube with flexible circular wings that attaches to the distal end of the endoscope to facilitate endoscopic therapy. The EndoRings is designed to fit specific endoscopes (as designated on the packaging), and is supplied sterile following ETO sterilization and is single use only. Indications for Use: To be attached to the distal end of the endoscope to facilitate endoscopic therapy, to be used for the following: * Keeping the suitable depth of endoscope's view field * Helping the endoscope with being inserted into the gastrointestinal tract Patient Population: The study population is comprised of patients indicated for colonoscopy. Study Design: Single-center study. A single treatment group of 60 patients. No. of Patients: Up to sixty (60) treated patients will be enrolled in the study. Primary Endpoints:The primary endpoint is reaching the cecum of the colon with the ENDORINGS™. Secondary Endpoints / Other Outcomes: 1. Incidence of complications (number of complications) 2. Ability to complete s therapeutic interventions as biopsies, polypectomies, APC etc. 3. Procedure time. 4. Ease of scope insertion, advancement and withdrawal. 5. Ability to center the scope inside the gastrointestinal tract. 6. Subjective evaluation of the additional area screened by the physician (recorded in the source documents by a questionnaire). 7. Patient satisfactory (by a follow up phone-call in which questionnaire with VAS scale will be filled out).

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: Yes

Locations

Elisha Medical Center, Haifa, Please Select, Israel

Contact Details

Name: Ian Gralnek, Prof.

Affiliation: Attending Physician at Elisha Hospital, Haifa, Israel ~~~~~ Chief, Hospital-Wide Ambulatory Care Services Head, GI Outcomes Unit and Senior Physician Department of Gastroenterology Rambam Health Care Campus Rappaport Faculty of Medicine, Technion-Israel

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: